The American Joint Replacement Registry (AJRR) is providing even more guidance for hospitals and surgeons to get the most out of their patient-reported outcome (PRO) platforms. The group has just published a guide on their new Level III PRO platform, meaning that users can better manage their PRO programs and can build them around the requirements provided in the guide.
AJRR Publishes Level III PRO Platform
1 min read Premium comments
Secondary
“PROs are becoming more and more important to health care, as the federal government continues to emphasize their use with programs and quality initiatives, ” said Daniel J. Berry, M.D., Chair of the AJRR Board of Directors, in the January 28, 2016 news release. “We want to ensure that our platform is relevant to practicing physicians, and that they are getting the most out of what we have to offer. Our new guide is perfect for pointing institutions in the right direction when forming a program and helping hospitals that already collect PROs to adjust in a way that makes data submission simpler.”
As indicated in the news release, “The guide features several tables that summarize the patient-reported outcome measures (PROMs) that the AJRR collects, and which specific measures are recommended. The AJRR realizes that some institutions may have long-standing PRO programs, so a variety of measures are available in the system. A list of questions that hospital staff might ask themselves before beginning a program are provided, along with two workflow diagrams. These diagrams show how data could be submitted into the Registry in either electronic or paper formats. A section devoted to the lessons learned from our participants is featured at the end of the document. The advice is based on previously-held focus groups and discussions with hospitals.”
“AJRR launched Level I data element reporting in 2012. We are proud to now be able to collect Level III data as well, ” said Dr. Berry. “Collecting PRO data and submitting it to a Registry provides many benefits for patients, hospitals, practices, and individual orthopaedic surgeons. With the guide, AJRR has made the process more straightforward and convenient than ever before.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.